141 related articles for article (PubMed ID: 7832476)
21. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide.
Tatsuno I; Somogyvari-Vigh A; Mizuno K; Gottschall PE; Hidaka H; Arimura A
Endocrinology; 1991 Oct; 129(4):1797-804. PubMed ID: 1655384
[TBL] [Abstract][Full Text] [Related]
22. Pituitary adenylate cyclase-activating peptide as a neurotransmitter in the canine ileal circular muscle.
Fox-Threlkeld JA; McDonald TJ; Woskowska Z; Iesaki K; Daniel EE
J Pharmacol Exp Ther; 1999 Jul; 290(1):66-75. PubMed ID: 10381761
[TBL] [Abstract][Full Text] [Related]
23. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a regulator of astrocytes: PACAP stimulates proliferation and production of interleukin 6 (IL-6), but not nerve growth factor (NGF), in cultured rat astrocyte.
Tatsuno I; Morio H; Tanaka T; Uchida D; Hirai A; Tamura Y; Saito Y
Ann N Y Acad Sci; 1996 Dec; 805():482-8. PubMed ID: 8993428
[No Abstract] [Full Text] [Related]
24. Neurotransmitters co-existing with VIP or PACAP.
Fahrenkrug J; Hannibal J
Peptides; 2004 Mar; 25(3):393-401. PubMed ID: 15134862
[TBL] [Abstract][Full Text] [Related]
25. Studies on the involvement of endogenous neuropeptides in the control of thymocyte proliferation in the rat.
Trejter M; Warchol JB; de Caro R; Brelinska R; Nussdorfer GG; Malendowicz LK
Histol Histopathol; 2001 Jan; 16(1):155-8. PubMed ID: 11193190
[TBL] [Abstract][Full Text] [Related]
26. PACAP-(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38).
Tornøe K; Hannibal J; Fahrenkrug J; Holst JJ
Am J Physiol; 1997 Aug; 273(2 Pt 1):G436-46. PubMed ID: 9277423
[TBL] [Abstract][Full Text] [Related]
27. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
[TBL] [Abstract][Full Text] [Related]
28. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression.
Delgado M; Ganea D
J Immunol; 2000 Jul; 165(1):114-23. PubMed ID: 10861043
[TBL] [Abstract][Full Text] [Related]
29. Pituitary adenylate cyclase activating polypeptide stimulates rat Leydig cell steroidogenesis through a novel transduction pathway.
Rossato M; Nogara A; Gottardello F; Bordon P; Foresta C
Endocrinology; 1997 Aug; 138(8):3228-35. PubMed ID: 9231772
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways.
Maduna T; Lelievre V
J Neurosci Res; 2016 Dec; 94(12):1472-1487. PubMed ID: 27717098
[TBL] [Abstract][Full Text] [Related]
31. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression.
Delgado M; Ganea D
J Immunol; 2000 Feb; 164(3):1200-10. PubMed ID: 10640731
[TBL] [Abstract][Full Text] [Related]
32. Pituitary adenylate cyclase-activating peptide in sensory and autonomic ganglia: localization and regulation.
Sundler F; Ekblad E; Hannibal J; Moller K; Zhang YZ; Mulder H; Elsås T; Grunditz T; Danielsen N; Fahrenkrug J; Uddman R
Ann N Y Acad Sci; 1996 Dec; 805():410-26; discussion 427-8. PubMed ID: 8993421
[No Abstract] [Full Text] [Related]
33. Changes in vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide and neuropeptide Y-ergic structures of the enteric nervous system in the carcinoma of the human large intestine.
Godlewski J; Łakomy IM
Folia Histochem Cytobiol; 2010 Jan; 48(2):208-16. PubMed ID: 20675276
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
[TBL] [Abstract][Full Text] [Related]
35. Localization and effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in human penile erectile tissue.
Hedlund P; Alm P; Hedlund H; Larsson B; Andersson KE
Acta Physiol Scand; 1994 Jan; 150(1):103-4. PubMed ID: 7907833
[No Abstract] [Full Text] [Related]
36. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.
Hedlund P; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Hedlund H; Larsson B; Andersson KE
Br J Pharmacol; 1995 Oct; 116(4):2258-66. PubMed ID: 8564257
[TBL] [Abstract][Full Text] [Related]
37. [The discovery of pituitary adenylate cyclase activating polypeptide (PACAP) and its research progress].
Geng L; Ju G
Sheng Li Ke Xue Jin Zhan; 1997 Jan; 28(1):29-34. PubMed ID: 10921074
[TBL] [Abstract][Full Text] [Related]
38. Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation.
Juarranz MG; Bodega G; Prieto JC; Guijarro LG
Prostate; 2001 Jun; 47(4):285-92. PubMed ID: 11398176
[TBL] [Abstract][Full Text] [Related]
39. Roles of peptides in enteric neuromuscular transmission.
Shuttleworth CW; Keef KD
Regul Pept; 1995 Apr; 56(2-3):101-20. PubMed ID: 7544470
[No Abstract] [Full Text] [Related]
40. Short- and long-term regulation of tyrosine hydroxylase in chromaffin cells by VIP and PACAP.
Haycock JW
Ann N Y Acad Sci; 1996 Dec; 805():219-30; discussion 230-1. PubMed ID: 8993405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
